As on Thursday, Bioventus Inc (NASDAQ: BVS) started slowly as it slid -1.92% to $11.25, before settling in for the price of $11.47 at the close. Taking a more long-term approach, BVS posted a 52-week range of $2.85-$12.41.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 10.81%. Meanwhile, its Annual Earning per share during the time was -51.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 1845.00%. This publicly-traded company’s shares outstanding now amounts to $63.27 million, simultaneously with a float of $40.72 million. The organization now has a market capitalization sitting at $733.39 million. At the time of writing, stock’s 50-day Moving Average stood at $9.93, while the 200-day Moving Average is $6.55.
Bioventus Inc (BVS) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Medical Devices industry. Bioventus Inc’s current insider ownership accounts for 37.54%, in contrast to 39.59% institutional ownership. According to the most recent insider trade that took place on Aug 16 ’24, this organization’s Director bought 80,000 shares at the rate of 8.55, making the entire transaction reach 683,736 in total value, affecting insider ownership by 6,913,857. Preceding that transaction, on Aug 19 ’24, Company’s Director bought 25,500 for 8.55, making the whole transaction’s value amount to 217,966. This particular insider is now the holder of 6,939,357 in total.
Bioventus Inc (BVS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.11 per share during the current fiscal year.
Bioventus Inc’s EPS increase for this current 12-month fiscal period is 1845.00% and is forecasted to reach 0.65 in the upcoming year.
Bioventus Inc (NASDAQ: BVS) Trading Performance Indicators
Let’s observe the current performance indicators for Bioventus Inc (BVS). It’s Quick Ratio in the last reported quarter now stands at 0.96. The Stock has managed to achieve an average true range (ATR) of 0.52. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.37. Similarly, its price to free cash flow for trailing twelve months is now 101.02.
In the same vein, BVS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.66, a figure that is expected to reach 0.02 in the next quarter, and analysts are predicting that it will be 0.65 at the market close of one year from today.
Technical Analysis of Bioventus Inc (BVS)
Through scrutinizing the latest numbers posted by the [Bioventus Inc, BVS], it can be observed that its last 5-days Average volume of 0.45 million was better the volume of 0.39 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 28.40% While, its Average True Range was 0.51.
Raw Stochastic average of Bioventus Inc (BVS) in the period of the previous 100 days is set at 83.73%, which indicates a major rise in contrast to 15.94% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 46.86% that was lower than 69.73% volatility it exhibited in the past 100-days period.
